ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.105
      -0.46%
      Bitcoin
      55,113.84
      -1.31%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Celgene Corporation (CELG)

      7. Celgene Corporation (CELG) News

      CELG

      Celgene (CELG)

      Celgene Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CELG
      DateTimeSourceHeadlineSymbolCompany
      10/24/20189:13AMBusiness WireTV Host and Fashion Journalist Louise Roe Shares Her Personal Story With Plaque Psoriasis as Part of INSIDE PERSPECTIVE Campa...NASDAQ:CELGCelgene Corporation
      10/23/20186:01PMDow Jones NewsCelgene Reports Positive Results From Revlimid TrialNASDAQ:CELGCelgene Corporation
      10/23/20184:30PMBusiness WireREVLIMID® (lenalidomide) Demonstrated a Significant Improvement in Progression-Free Survival (PFS) Compared with Observation...NASDAQ:CELGCelgene Corporation
      10/22/20184:30PMBusiness WireCelgene Corporation Announces Appointment of Dr. Alise Reicin to President, Global Clinical DevelopmentNASDAQ:CELGCelgene Corporation
      10/22/20187:30AMBusiness WireFirst Results of New Data of ABRAXANE in Combination with Atezolizumab Presented at ESMO 2018NASDAQ:CELGCelgene Corporation
      10/19/20187:03PMDow Jones NewsPain Treatment Developer Centrexion Reveals IPO PlansNASDAQ:CELGCelgene Corporation
      10/18/201810:00AMBusiness WireNeue Analysen aus zulassungsrelevanten Phase-III-Studien zu oral verabreichtem Ozanimod auf dem ECTRIMS-Kongress 2018 vorgest...NASDAQ:CELGCelgene Corporation
      10/17/20187:01PMDow Jones NewsOncoMed Says Celgene Won't Exercise Option to License RosmantuzumabNASDAQ:CELGCelgene Corporation
      10/11/20187:30AMBusiness WireSurvey Results Presented at ECTRIMS Reveal People with Multiple Sclerosis Want More Information on Brain AtrophyNASDAQ:CELGCelgene Corporation
      10/10/20187:30AMBusiness WireNew Analyses from Pivotal Phase 3 Trials of Oral Ozanimod to Be Presented at ECTRIMS 2018NASDAQ:CELGCelgene Corporation
      10/08/20185:44PMDow Jones NewsCelgene Says Phase 3 Study of Otezla Met Primary EndpointNASDAQ:CELGCelgene Corporation
      10/08/20184:37PMBusiness WireCelgene Announces Phase 3 STYLE Study of OTEZLA® (apremilast) in Moderate to Severe Scalp Psoriasis Met Primary EndpointNASDAQ:CELGCelgene Corporation
      10/01/20187:30AMBusiness WireCelgene Corporation to Announce Third Quarter 2018 Results on October 25, 2018NASDAQ:CELGCelgene Corporation
      09/24/201810:01AMPR Newswire (US)S&P 500 Q2 2018 Buybacks Increase 58.7% Year-Over-Year to Record $190.6 BillionNASDAQ:CELGCelgene Corporation
      09/20/20188:59AMDow Jones NewsOncoMed Says Celgene Won't Exercise Option to License NavicixizumabNASDAQ:CELGCelgene Corporation
      09/18/20182:00AMBusiness WireApremilast (OTEZLA®) erzielte bei Plaque-Psoriasis bedeutsame Verbesserungen in klinischen und lebensqualitätsbezogenen End...NASDAQ:CELGCelgene Corporation
      09/17/20182:30AMBusiness WireApremilast mostra nei pazienti con psoriasi miglioramenti clinici e di qualità della vita significativi, che vanno oltre la ...NASDAQ:CELGCelgene Corporation
      09/12/20187:30AMBusiness WireOTEZLA® (Apremilast) Showed Meaningful Improvements in Clinical & Quality-of-Life Measures of Psoriasis Beyond Those Capture...NASDAQ:CELGCelgene Corporation
      09/04/20186:27PMDow Jones NewsFormer Celgene Executive Fouse to Become Agios Pharmaceuticals CEONASDAQ:CELGCelgene Corporation
      08/23/20187:30AMBusiness WireCelgene Corporation to Webcast at Upcoming Investor ConferencesNASDAQ:CELGCelgene Corporation
      08/13/20184:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      08/07/20185:48PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:CELGCelgene Corporation
      08/07/20184:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      08/03/20184:07PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CELGCelgene Corporation
      08/01/20184:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      08/01/20184:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      08/01/20184:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      08/01/20184:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      08/01/20184:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      08/01/20184:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
       Showing the most relevant articles for your search:NASDAQ:CELG